An increase in galectin-3 identifies males at risk of new-onset HF and new-onset cancer

5' education - June 15, 2022 - Freek van den Berg, MD - Groningen, The Netherlands

Educational information

This video was recorded during the ESC Heart Failure Congress 2022 in Madrid, Spain.

Faculty

Freek van den Berg, MD, is a PhD candidate at the University Medical Center Groningen in The Netherlands.

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.